11 completed, 1 terminated, 1 unknown. 13 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 11, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow VAP-cyclo protocol: new trials by email Literature Review of VAP-cyclo protocol trials Research Report on VAP-cyclo protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL CEOP regimen, CHOP regimen - Lymphoma | Phase 3 | Completed | Fudan University | 398 | 2009-03-01 | 2014-08-20 |
| Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma CHOP regimen, EPOCH regimen, cyclophosphamide - Lymphoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 3 | 2003-03-01 | 2012-09-24 |
| Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma rituximab, CHOP regimen - Lymphoma | Phase 3 | Completed | NCIC Clinical Trials Group | 824 | 2001-05-08 | 2020-04-01 |
| Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma filgrastim, rituximab, CHOP regimen - Lymphoma | Phase 3 | Completed | German High-Grade Non-Hodgkin's Lymphoma Study Group | 1506 | 2001-01-01 | 2021-05-18 |
| Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma rituximab, CHOP regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | University of Nebraska | 1999-09-01 | 2024-09-23 | |
| Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma rituximab, CHOP regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 475 | 1999-05-01 | 2021-02-15 |
| Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma filgrastim, rituximab, CHOP regimen - Lymphoma | Phase 3 | Completed | National Cancer Institute (NCI) | 120 | 1999-01-01 | 2013-02-08 |
| Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma bleomycin sulfate, CHOP regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | Lymphoma Trials Office | 310 | 1998-01-01 | 2013-06-26 |
| Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma rituximab, CHOP regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | Eastern Cooperative Oncology Group | 630 | 1997-12-01 | 2013-06-21 |
| SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma rituximab, CHOP regimen, carmustine - Lymphoma | Phase 3 | Completed | SWOG Cancer Research Network | 397 | 1997-07-01 | 2021-02-02 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma filgrastim, CHOP regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | Swiss Cancer Institute | 400 | 1997-04-01 | 2012-05-15 |
| Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma bleomycin sulfate, CHOP regimen, cisplatin - Lymphoma | Phase 3 | Completed | M.D. Anderson Cancer Center | 61 | 1994-05-25 | 2018-11-14 |
| High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma CHOP regimen, carmustine, cyclophosphamide - Lymphoma | Phase 3 | Unknown | Lymphoma Trials Office | 500 | 1993-01-01 | 2013-09-20 |
Lymphoma (13) · Lymphoma, Large B-Cell, Diffuse (10) · Lymphoma, Non-Hodgkin (7) · Lymphoma, Follicular (6) · Lymphoma, Large-Cell, Immunoblastic (6) · Burkitt Lymphoma (3) · Lymphoma, Large-Cell, Anaplastic (3) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Mantle-Cell (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Cardiotoxicity (1) · Immunoblastic Lymphadenopathy (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell (1) · Lymphoma, T-Cell, Cutaneous (1)
European Organisation for Research and Treatment of Cancer - EORTC (2) · Lymphoma Trials Office (2) · Eastern Cooperative Oncology Group (1) · Fudan University (1) · German High-Grade Non-Hodgkin's Lymphoma Study Group (1) · M.D. Anderson Cancer Center (1) · NCIC Clinical Trials Group (1) · National Cancer Institute (NCI) (1) · SWOG Cancer Research Network (1) · Swiss Cancer Institute (1) · University of Nebraska (1)
United States (5) · Canada (3) · United Kingdom (3) · Belgium (2) · Denmark (2) · Germany (2) · Italy (2) · Norway (2) · Switzerland (2) · Australia (1) · Austria (1) · Brazil (1) · Chile (1) · China (1) · Czechia (1)
Daniel C. Betticher, MD (1) · David C. Linch (1) · David P. Schenkein, MD (1) · Eva K. Kimby, MD, PhD (1) · Fernando Cabanillas, MD (1) · James K. Weick, MD (1) · Julie M Vose, MD (1) · Kevin Imrie, MD (1) · Lawrence D. Kaplan, MD (1) · Max M. Wolf, MD (1) · Michael G.M. Pfreundschuh, MD (1) · Patrick J. Stiff, MD (1) · Pierre Soubeyran, MD, PhD (1) · Richard J. Klasa, MD (1)
PMID 15914552, PMID 16449523, PMID 16648042, PMID 16754935, PMID 16873669, PMID 16888080, PMID 18226581, PMID 18400558, PMID 20368567, PMID 20371683, PMID 20439641, PMID 20735398, PMID 22337718, PMID 23335369, PMID 24171516, PMID 24493716, PMID 24625415, PMID 25135997, PMID 25403207, PMID 27967294, PMID 28398499, PMID 34384709, PMID 39227453
P30CA036727 (1), U10CA032102 (1)